3 completed. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Argus Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Nystatin in HIV-Infected Patients Nystatin, Didanosine - HIV Infections | Phase 1 | Completed | Argus Pharmaceuticals | 2005-06-24 | ||
| A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection. Nystatin - HIV Infections | Phase 1 | Completed | Argus Pharmaceuticals | 2005-06-24 | ||
| Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC) Nystatin - HIV Infections | Not applicable | Completed | Argus Pharmaceuticals | 2005-06-24 |
AIDS-Related Complex (3) · Acquired Immunodeficiency Syndrome (3) · HIV Infections (3)
Nystatin (3) · Didanosine (1)
United States (3)